Dividend stocks are attractive for their steady income, stability, and growth potential, especially amid low interest rates ...

However, arguably the next best thing is for a company to belong to the elite group known as Dividend Kings. To qualify, a ...

If you're investing in stocks that have long track records for increasing their payouts, odds are, you're buying shares of ...

A long history of consistently increasing dividends is highly valued by Lynch. His guides are to look for companies with a track record of stable dividends for at least 20 years. Both ABBV and PFE ...

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two ...

Which healthcare stock can dividend investors safely buy? Let's consider two excellent options: AbbVie (NYSE: ABBV) and Amgen ...

Dividend yield and robust drug pipeline are bullish ... Data by YCharts Shares of AbbVie experienced one of their worst ...

As most advisors are well aware, high stock prices have pushed down the market’s dividend yield. Barron’s ran a screen for ...

In trading on Monday, shares of AbbVie crossed below their 200 day moving average of $178.81, changing hands as low as $172.70 per share.

Cerevel wasn't a one-trick pony, however. For its considerable spend, AbbVie also acquired several other pipeline programs from the neuroscience-focused biotech. The most promising of these is ...

Dividend growth stocks offer a unique blend of reliability and growth potential, making them an ideal choice for long-term ...